Table 1.
Sociodemographic and clinical data.
| Intervention n = 76 | Control n = 45 | |
|---|---|---|
| Age (mean ± SD) | 51.0 ± 10.3 | 53.5 ± 12.8 |
| Gender (%Female) | 60.5 | 48.9 |
| % on anti-hypertensive medication | 61.8 | 88.9 |
| Baseline SBP | 151.6 ± 11.7 | 155.9 ± 10.6 |
| Baseline DBP | 93.9 ± 8.8 | 88.7 ± 12.2 |
| SBP after 6 weeks | 128.6 ± 9.2 | 151.4 ± 10.7 |
| DBP after 6 weeks | 81.9 ± 7.7 | 85.1 ± 7.9 |
| Mean reduction SBP * | 23.1 ± 11.8 | 4.4 ± 10.2 |
| Mean reduction DBP ** | 12.0 ± 11.2 | 3.6 ± 8.7 |
SBP: systolic blood pressure expressed in mmHg (mean ± SD), DBP: diastolic blood pressure expressed in mmHg (mean ± SD); * p < 0.00001 ** p = 0.00003.